Abametapir for the Treatment of Head Lice: A Drug Review
Sign Up to like & getrecommendations! Published in 2021 at "Annals of Pharmacotherapy"
DOI: 10.1177/10600280211027968
Abstract: Objective This article reviews the pharmacology, safety, efficacy, and clinical importance of abametapir 0.74% (Xeglyze) for the treatment of head lice. Data Sources From 2020 to May 2021, a systematic review of the MEDLINE and… read more here.
Keywords: treatment head; treatment; abametapir; head lice ... See more keywords